The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Cancer immunotherapy has received tremendous attention in the past decade owing to its clinical successes with the use of immune‐checkpoint inhibition and chimeric antigen receptor T cell therapy. However, only a small proportion of the patients have benefited from these immunotherapeutic drugs, which has raised concerns about the low response rate and immune‐related adverse events. Nanomedicines...
Cell membrane‐camouflaged phototherapeutic nanoparticles have appealing properties of immune escape, in vivo prolonged circulation time, and homologous targeting, and their phototherapeutic activities remain nearly unchanged. In article number 1804105, Kanyi Pu and co‐workers highlight recent advances in the development of biomimetic cell membrane‐camouflaged nanoparticles for cancer phototherapy...
Phototherapy including photothermal therapy (PTT) and photodynamic therapy (PDT) employs phototherapeutic agents to generate heat or cytotoxic reactive oxygen species (ROS), and has therefore garnered particular interest for cancer therapy. However, the main challenges faced by conventional phototherapeutic agents include easy recognition by the immune system, rapid clearance from blood circulation,...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.